What is Emergent Biosolutions Inc Quarterly Revenue?

Emergent Biosolutions Inc Quarterly Revenue Emergent Biosolutions Inc Jun-2026 Quarterly Revenue is $227 Million which is growth of 74.1% YoY.

What is Emergent Biosolutions Inc Quarterly Net Profit?

Emergent Biosolutions Inc Quarterly Net Profit Emergent Biosolutions Inc Jun-2026 Quarterly Net Profit is $-180 Million which is growth of -1401.7% YoY.

What is Emergent Biosolutions Inc Annual Revenue?

Emergent Biosolutions Inc Annual Revenue Emergent Biosolutions Inc Dec-2025 Annual Revenue is $705 Million which is growth of -30.4% YoY.

What is Emergent Biosolutions Inc Annual Net Profit?

Emergent Biosolutions Inc Annual Net Profit Emergent Biosolutions Inc Dec-2025 Annual Net Profit is $53 Million which is growth of 127.6% YoY.

What is Emergent Biosolutions Inc Total Shareholders Fund?

Emergent Biosolutions Inc Total Shareholders Fund Emergent Biosolutions Inc Dec-2025 Total Shareholders Fund is $523 Million which is growth of 8.2% YoY.

What is Emergent Biosolutions Inc Total Assets?

Emergent Biosolutions Inc Total Assets Emergent Biosolutions Inc Dec-2025 Total Assets is $1,319 Million which is growth of -5.1% YoY.

What is Emergent Biosolutions Inc Book Value Per Share?

Emergent Biosolutions Inc Book Value Per Share Emergent Biosolutions Inc Book Value Per Share is $11 which is growth of 19.5% YoY.

What is Emergent Biosolutions Inc ROE?

Emergent Biosolutions Inc ROE Emergent Biosolutions Inc ROE is 0% which is growth of 0% YoY.

What is Emergent Biosolutions Inc Cash From Operating Activity?

Emergent Biosolutions Inc Cash From Operating Activity Emergent Biosolutions Inc Dec-2025 Cash From Operating Activity is $171 Million which is growth of 190.6% YoY.

What is Emergent Biosolutions Inc Net Cash Flow?

Emergent Biosolutions Inc Net Cash Flow Emergent Biosolutions Inc Dec-2025 Net Cash Flow is $103 Million which is growth of 1795.1% YoY.

Emergent Biosolutions Inc

XNYS: EBS

Await Turnaround

Download real time

0.00(0.00%)

50.85% Fall from 52W High

761.1K

XNYS Volume

XNYS 14 Oct, 2026 5:30 PM (EDT)

Portfolio

Alert

My Notes

Emergent Biosolutions Inc quarterly and annual earnings report: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents

View Charts

Forecaster Analyst Estimates for Emergent Biosolutions Inc share price target, revenues, EPS, net income and more

Emergent Biosolutions Inc quarterly results: revenue, profit, and P&L – 13 quarter history

Nested row level

Base Level

Reporting Type

Originally Reported

Cell Data

Actual

Table Settings

YoY & New to Old

Nested row level

Base Level

Export

POSITIVE
Quarterly Revenue Emergent Biosolutions Inc Jun-2026 Quarterly Revenue is $227 Million which is growth of 74.1% YoY.
NEGATIVE
Quarterly Net Profit Emergent Biosolutions Inc Jun-2026 Quarterly Net Profit is $-180 Million which is growth of -1401.7% YoY.

Emergent Biosolutions Inc, Earnings Report - Quarterly Results, standalone, All financials are in USD Million and price data in USD
Indicator	Jun '26	Mar '26	Dec '25	Sep '25	Jun '25	Mar '25	Dec '24	Sep '24	Jun '24	Mar '24	Dec '23	Sep '23	Jun '23
SR_Q Operating Rev.	226.8	149.7	143.8	222	130.3	209.1	189.3	283.8	248.1	292.4	269.9	264	331.3
CostOfRevenue_Q Cost Of Rev.	97.1	72	84.9	85.9	66.9	88.5	118	122.6	296.1	144.6	185.1	176.8	190.6
GrossProfit_Q Gross Profit	129.7	77.7	58.9	136.1	63.4	120.6	71.3	161.2	-48	147.8	84.8	87.2	140.7
OEXPNS_Q Operating Exp. ⌄	63.5	67.2	74.6	59.6	61.8	70.7	80.8	96.7	128.3	108	128.6	111.1	126.9
AdminAndSellingExpenses_Q Admin Plus Selling Exp.	44.6	46.6	51.1	38.9	43.7	52.4	60.8	76.6	85.9	84.7	89.7	86	91.4
ResearchAndDevlopmentExpenses_Q RnD Exp.	9.2	10.5	12.1	13.5	12.5	15.1	9.1	13.8	32.7	15.1	29.4	15.3	26
OP_Q Operating Profit	66.2	10.5	-15.7	76.5	1.6	49.9	-9.5	64.5	-176.3	39.8	-43.8	-23.9	13.8
NetNonOperIntIncExp_Q Net Non Operations Interest Incuding Expenses ⌄	-10	-11	-14.7	-15.2	-14.7	-14.7	-14.8	-8.3	-23.6	-24.3	-21.7	-19.7	-28.6
Others_Q Other Interest Earned	-	-	-	-	-	-	-	-	-	-	-	-	-
IntExpNonOperating_Q Interest Exp. Non Operating	10	11	14.7	15.2	14.7	14.7	14.8	8.3	23.6	24.3	21.7	19.7	28.6
PBT_Q Profit Before Tax	-166.3	13.4	-50.7	57.6	-16.8	92.7	-27.6	142.4	-269.8	12.1	-54.5	-265.9	-250.2
TAX_Q Tax	13.9	6.6	3.9	6.4	-4.8	24.7	3.7	27.6	13.3	3.1	-5	-2.5	11.1
NICommonStockholders_Q Net Income Common Stockholders ⌄	-180.2	6.8	-54.6	51.2	-12	68	-31.3	114.8	-283.1	9	-49.5	-263.4	-261.3
NP_Q Net Profit	-180.2	6.8	-54.6	51.2	-12	68	-31.3	114.8	-283.1	9	-49.5	-263.4	-261.3
NIIncludingNoncontrollingInterests_Q Net Income Including Non controlling Interests	-180.2	6.8	-54.6	51.2	-12	68	-31.3	114.8	-283.1	9	-49.5	-263.4	-261.3
DilutedNIAvailtoComStockholders_Q Diluted NI Avail to Com Stockholders Ann.	-180.2	6.8	-54.6	51.2	-12	68	-31.3	114.8	-283.1	9	-49.5	-263.4	-261.3
EPS_Q Basic EPS	-3.5	0.1	-1	1	-0.2	1.3	-0.6	2.2	-5.4	0.2	-1	-5.1	-5.2
AfterDilutedEPS_Q Diluted EPS After ExtraOrdinary	0.6	0.2	-0.4	1.1	0.2	0.7	0.1	1.4	-2.3	0.6	-0.8	-0.9	-1.1
SHARE_Q Number Of Shares End	51.6	51.9	52.3	53.2	54.2	54.4	54.2	53.1	52.6	52.2	52.1	51.8	50.7
NIContinuingDiscontinuedOper_Q Net Income Continuing Discontinued Operations	-180.2	6.8	-54.6	51.2	-12	68	-31.3	114.8	-283.1	9	-49.5	-263.4	-261.3
NormalizedIncome_Q Normalized Income	30.9	11.9	-22.7	60.4	8.6	40.7	2.6	76.2	-122	31.1	-40	-40.6	-53.5
InterestIncome_Q Interest Income	-	-	-	-	-	-	-	-	-	-	-	-	-
INT_Q Interest	10	11	14.7	15.2	14.7	14.7	14.8	8.3	23.6	24.3	21.7	19.7	28.6
NetInterestIncome_Q Net Interest Income	-10	-11	-14.7	-15.2	-14.7	-14.7	-14.8	-8.3	-23.6	-24.3	-21.7	-19.7	-28.6
EBIT_Q EBIT	-156.3	24.4	-36	72.8	-2.1	107.4	-12.8	150.7	-246.2	36.4	-32.8	-246.2	-221.6
EBITDA_Q EBITDA	-132.3	47.9	-12.5	96.2	21.4	132.8	13.2	177.1	-217.7	64.3	-3.2	-218.2	-188.7
ReconciledCostOfRevenue_Q Reconciled Cost Of Rev.	90.3	65	77.7	78.8	59.6	79.4	108.3	112.5	283.9	132.9	171.7	165.1	173.8
ReconciledDepreciation_Q Reconciled Depr.	24	23.5	23.5	23.4	23.5	25.4	26	26.4	28.5	27.9	29.6	28	32.9
ProfitLossFromContinuingOperations_Q Profit From Continuing Operations	-180.2	6.8	-54.6	51.2	-12	68	-31.3	114.8	-283.1	9	-49.5	-266.7	-261.3
NormalizedEBITDA_Q Normalized EBITDA	90.2	47.9	-0.3	96.2	21.4	145	13.2	112.8	-150.5	64.3	-3.2	0.7	43.1

*All financials are in USD Million and price data in USD

Add metric to table

Search...

Emergent Biosolutions Inc competitor comparison and performance snapshot within industry

Emergent Biosolutions Inc annual results: revenue, profit, P&L, and margins as of Dec 2025 – 11 year history

Nested row level

Base Level

Reporting Type

Originally Reported

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

NEGATIVE
Annual Revenue Emergent Biosolutions Inc Dec-2025 Annual Revenue is $705 Million which is growth of -30.4% YoY.
POSITIVE
Annual Net Profit Emergent Biosolutions Inc Dec-2025 Annual Net Profit is $53 Million which is growth of 127.6% YoY.

Emergent Biosolutions Inc, Earnings Report - Annual Results, standalone, All financials are in USD Million and price data in USD
Indicator	CAGR 3 Yrs	CAGR 5 Yrs	TTM	Dec '25	Dec '24	Dec '23	Dec '22	Dec '21	Dec '20	Dec '19	Dec '18	Dec '17	Dec '16	Dec '15
SR_A Total Rev. Ann. ⌄	-13.2%	-13.3%		705.2	1,013.6	1,023	1,079.5	1,658.5	1,440.3	983.5	705.4	490.5	345.4	399.9
TotalOperatingRevenues_A Operating Rev. Ann.	-13.2%	-13.3%	742.3	705.2	1,013.6	1,023	1,079.5	1,658.5	1,440.3	983.5	705.4	490.5	345.4	399.9
CostOfRevenue_A Cost Of Rev. Ann.	-22.2%	-9%	339.9	326.2	681.3	705.4	693.7	757.5	524	433.5	322.3	195.7	131.3	124.3
GrossProfit_A Gross Profit Ann.	-0.6%	-16.2%	402.4	379	332.3	317.6	385.8	901	916.3	550	383.1	294.7	214.1	275.6
OEXPNS_A Operating Exp. Ann.	-21.5%	-11.2%	264.9	266.7	413.8	519.1	551.8	506.7	482.5	435.9	293.3	170.5	108.6	179.6
OP_A Operating Profit Ann.	-	-23.7%	137.5	112.3	-81.5	-201.5	-166	394.3	433.8	114.1	89.8	124.3	105.5	96
NetNonOperIntIncExp_A Net Non Operations Interest Incuding Expenses Ann, ⌄	-	-	-50.9	-59.3	-71	-87.9	-37.3	-34.5	-31.3	-38.4	-9.9	-4.8	-6.6	-6
Others_A Other Interest Earned Ann.	-	-		-	-	-	-	-	-	-	-	1.8	1.1	0.6
IntExpNonOperating_A Interest Exp. Non Operating Ann.	16.7%	13.6%	50.9	59.3	71	87.9	37.3	34.5	31.3	38.4	9.9	6.6	7.6	6.5
OtherExpenses_A Other Exp. Ann.	-	44.7%		29.8	9.6	-441.8	-18.4	-45.4	4.7	1.7	1.6	-0.8	0.3	-0.3
PBT_A PBT Ann.	-	-27.3%	-146	82.8	-142.9	-731.2	-221.7	314.4	407.2	77.4	81.5	118.6	99.2	89.8
TAX_A Tax Ann.	143.2%	-21.6%	30.8	30.2	47.7	29.3	2.1	83.5	102.1	22.9	18.8	36	36.7	26.9
NICommonStockholders_A Net Income Common Stockholders Ann. ⌄	-	-29.6%	-176.8	52.6	-190.6	-760.5	-223.8	230.9	305.1	54.5	62.7	82.6	51.8	62.9
NP_A Net Profit Ann.	-	-29.6%	-176.8	52.6	-190.6	-760.5	-223.8	230.9	305.1	54.5	62.7	82.6	51.8	62.9
NIIncludingNoncontrollingInterests_A Net Income Including Non controlling Interests Ann.	-	-29.6%	-176.8	52.6	-190.6	-760.5	-223.8	230.9	305.1	54.5	62.7	82.6	51.8	62.9
DilutedNIAvailtoComStockholders_A Diluted NI Avail to Com Stockholders Ann.	-	-29.6%	-176.8	52.6	-190.6	-760.5	-223.8	230.9	305.1	54.5	62.7	85.9	55.8	66.8
EPS_A EPS Ann.	-	-29.6%		1	-3.6	-14.9	-4.5	4.3	5.8	1.1	1.3	2	1.3	1.6
DilutedEPS_A Diluted EPS Ann.	-	-30.9%		0.9	-3.6	-14.9	-4.5	4.3	5.7	1	1.2	1.7	1.1	1.4
SHARE_Q Number Of Shares End	1.6%	-0.4%		52.3	54.2	52.1	49.8	53.2	53.3	51.8	50.9	44.3	40.5	39.1
TotalExpenses_A Total Exp. Ann.	-21.9%	-10%		592.9	1,095.1	1,224.5	1,245.5	1,264.2	1,006.5	869.4	615.6	366.2	239.9	303.8
NIContinuingDiscontinuedOper_A Net Income Continuing Discontinued Operations Ann.	-	-29.6%	-176.8	52.6	-190.6	-760.5	-223.8	230.9	305.1	54.5	62.7	82.6	51.8	62.9
NormalizedIncome_A Normalized Income Ann.	-	-27.2%	80.5	86.8	-12.1	-319	-111.9	325.7	423.9	152.3	119.6	95.7	77.5	75.6
InterestIncome_A Interest Income Ann.	-	-		-	-	-	-	-	-	-	-	1.8	1.1	0.6
INT_A Interest Ann.	16.7%	13.6%	50.9	59.3	71	87.9	37.3	34.5	31.3	38.4	9.9	6.6	7.6	6.5
EBITDA_A EBITDA Ann.	-	-15.5%	-0.7	237.9	36.9	-518.2	-41.1	472.7	553	226.5	153.6	166	144	131.1
ReconciledCostOfRevenue_A Reconciled Cost Of Rev. Ann.	-21.5%	-8.8%	311.8	295.5	637.6	645.9	610.3	692.2	469.3	381.5	285.1	195.7	131.3	124.3
ReconciledDepreciation_A Reconciled Depr. Ann.	-12.6%	-3.5%	94.4	95.8	108.8	125.1	143.3	123.8	114.5	110.7	62.2	42.6	38.2	35.3
ProfitLossFromContinuingOperations_A Profit From Continuing Operations Ann.	-	-29.6%	-176.8	52.6	-190.6	-760.5	-223.8	230.9	305.1	54.5	62.7	82.6	51.8	62.9
NormalizedEBITDA_A Normalized EBITDA Ann.	-	-13.9%	234	262.3	39.8	-67.5	-34.4	514.4	553	226.5	153.6	167.8	145.1	131.6

*All financials are in USD Million and price data in USD

Add metric to table

Search...

Total Rev. Ann.

1Y CHG

-30.4%

2Y CAGR

-17%

3Y CAGR

-13.2%

5Y CAGR

-13.3%

7Y CAGR

10Y CAGR

5.8%

Total Revenue Annual is falling faster than historical averages.

Net Profit Ann.

5Y CAGR

-29.6%

7Y CAGR

-2.5%

10Y CAGR

-1.8%

Net Profit Annual growth is stable compared to historical averages.

Operating Exp. Ann.

1Y CHG

-35.5%

2Y CAGR

-28.3%

3Y CAGR

-21.5%

5Y CAGR

-11.2%

7Y CAGR

-1.3%

10Y CAGR

Operating Expenses Annual Cr is falling faster than historical averages.

Emergent Biosolutions Inc balance sheet as of Dec 2025: assets, liabilities, reserves, and borrowings – 11 year history

Nested row level

Base Level

Reporting Type

Originally Reported

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

POSITIVE
Total Shareholders Fund Emergent Biosolutions Inc Dec-2025 Total Shareholders Fund is $523 Million which is growth of 8.2% YoY.
NEGATIVE
Total Assets Emergent Biosolutions Inc Dec-2025 Total Assets is $1,319 Million which is growth of -5.1% YoY.

Emergent Biosolutions Inc, Balance Sheet, standalone, All financials are in USD Million and price data in USD
Indicator	CAGR 3 Yrs	CAGR 5 Yrs	Dec '25	Dec '24	Dec '23	Dec '22	Dec '21	Dec '20	Dec '19	Dec '18	Dec '17	Dec '16	Dec '15
TA_A Total Assets Ann. ⌄	-25.3%	-14.5%	1,318.6	1,389.7	1,823.2	3,166.6	2,959	2,883.2	2,327.3	2,229.4	1,070.2	970.1	1,043.6
CA_A Total Current Assets Ann.	-18.2%	-11.1%	662.5	598.7	679.5	1,210.7	1,272.1	1,195.9	686.2	620.8	485.4	510.2	538.6
CashEquivalentsShortTermInvestments_A Cash Equivalents and Short Term Investments Ann.	-31.6%	-19.9%	205.4	99.5	111.7	642.6	576.1	621.3	167.8	112.2	178.3	271.5	312.8
Receivables_A Change In Account Receivables Ann.	-19%	-18.3%	84.2	154.5	191	158.4	274.7	230.9	275.3	271.1	146.1	148.5	127.3
Inventories_A Inventories Ann.	-0.8%	2.3%	343.4	311.7	328.9	351.8	350.8	307	222.5	205.8	142.8	74	76.9
OtherCurrentAssets_A Other Current Assets Ann.	-23.6%	-	25.8	26.9	47.9	57.9	-	-	-	-	-	-	-
TotalNonCurrentAssets_A Total Non Current Assets Ann.	-30.5%	-17.2%	656.1	791	1,143.7	1,955.9	1,686.9	1,687.3	1,641.1	1,608.6	584.8	459.9	505
NetPPE_A Net PPE Ann.	-36.9%	-20.4%	205.4	270.6	382.8	817.6	800.1	644.1	542.3	510.2	407.2	376.5	331.9
InvestmentsAndAdvances_A Investments & Advances Ann.	-	-	-	-	-	-	-	-	-	-	-	-	-
OtherNonCurrentAssets_A Other Non Current Assets Ann.	-58%	-34%	14.2	18.9	194.3	191.3	57.3	113.4	76.9	13.7	6.1	2.5	7.1
TotalLiabilitiesNetMinorityInterest_A Total Liabilities Net Minority Interest Ann. ⌄	-23.6%	-11.1%	796	906.9	1,173.9	1,783.6	1,340	1,436.2	1,238.8	1,218.5	157.9	373.9	383.6
CL_A Total Current Liabilities Ann.	-52.5%	-19.2%	132.2	162.4	651.3	1,229.9	373.8	384.5	216.3	200.4	100.1	105.9	99.6
PayablesAndAccruedExpenses_A Payables & Accrued Exp.s Ann.	-18.6%	-16.4%	74.6	78.6	130.8	138.4	180.6	183	134.3	115.9	46.6	41	52.2
CurrentDebtCapLeaseObligation_A Current Debt Cap Lease Obligation Ann.	-	-	-	-	413.7	957.3	31.6	33.8	12.9	10.1	-	20	-
CurrentDeferredLiabilities_Q Current Deferred Liabilities	-	-	-	-	-	-	-	-	-	10.6	13.2	7	7.9
OtherCurrentLiabilities_A Other Current Liabilities Ann.	-29.9%	-28.3%	15.8	27.7	32.7	45.9	72.9	83.1	6.7	5.6	2.4	3.3	2.6
TotalNonCurrentLiabilities_A Total Non Current Liabilities Ann.	6.2%	-8.8%	663.8	744.5	522.6	553.7	966.2	1,051.7	1,022.5	1,018.1	57.8	268.1	284
LongTermDebtAndCapitalLeaseObligation_Q LT Debt & Capital Lease Obligation	8.5%	-7.4%	572.1	663.7	446.5	448.5	809.4	841	798.4	784.5	13.5	248.1	253
TradeandOtherPayablesNonCurrent_A Trade & Other Payables Non Current Ann.	-	-	-	-	-	-	-	-	-	11.2	12.5	-	-
TotalDeferredCreditsAndOtherNonCurrentLiabilities_A Total Deferred Credits & Other Non Current Liabilities Ann.	-	-	-	-	-	-	-	-	-	-	-	-	-
TotalShareHoldersFunds_A Total ShareHolders Funds Ann. ⌄	-27.7%	-18.4%	522.6	482.8	649.3	1,383	1,619	1,447	1,088.5	1,010.9	912.3	596.2	660
EQCAP_A Equity Share Capital Ann.	-27.7%	-18.4%	522.6	482.8	649.3	1,383	1,619	1,447	1,088.5	1,010.9	912.3	596.2	660
CapitalStock_A Capital Stock Ann.	0%	0%	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0
RetainedEarnings_A Retained Earnings Ann.	-	-	-159.8	-212.4	-21.8	734	957.8	726.9	421.8	367.3	337.1	254.5	351.1
GainsLossesNotAffectingRetainedEarnings_A Gains Losses Not Affecting Retained Earnings Ann.	-	-	-7.5	-5.2	-5.7	3.1	-16.1	-25.3	-9.9	-5.5	-3.7	-4.3	-2.7
TotalCapitalization_A Total Capitalization Ann.	-15.8%	-13.7%	1,094.7	1,146.5	1,095.8	1,831.5	2,428.4	2,288	1,886.9	1,795.4	925.8	844.3	913
TangibleAssets_A Tangible Assets Ann.	-41.8%	-30.1%	86.1	-18.7	82.7	436	789.5	517.2	80	-60.4	743.6	521.3	505.2
WC_A Working Capital Ann.	-	-8.2%	530.3	436.3	28.2	-19.2	898.3	811.4	469.9	420.4	385.3	404.4	439
InvestedCapital_A Invested Capital Ann.	-26.8%	-14%	1,094.7	1,146.5	1,509.5	2,788.8	2,460	2,321.8	1,899.8	1,805.5	925.8	864.3	913
TangibleBookValue_A Tangible Book Value Ann.	-41.8%	-30.1%	86.1	-18.7	82.7	436	789.5	517.2	80	-60.4	743.6	521.3	505.2
Borrowings_A Borrowings Ann.	-25.9%	-8.1%	572.1	663.7	860.2	1,405.8	841	874.8	811.3	794.6	13.5	268.1	253
NetDebt_A Net Debt Ann.	-21.7%	7.7%	366.7	564.2	748.5	763.2	264.9	253.5	643.5	682.4	-	-	-
ShareIssued_A Share Issued Ann.	3%	2.3%	60.8	59.9	57.8	55.7	55.1	54.3	52.9	52.4	50.6	41	39.8
SHARE_Q Number Of Shares End	1.6%	-0.4%	52.3	54.2	52.1	49.8	53.2	53.3	51.8	50.9	44.3	40.5	39.1

*All financials are in USD Million and price data in USD

Add metric to table

Search...

Total Assets Ann.

1Y CHG

-5.1%

2Y CAGR

-15%

3Y CAGR

-25.3%

5Y CAGR

-14.5%

7Y CAGR

-7.2%

10Y CAGR

2.4%

Total Assets Annual is falling slower than historical averages.

Total Current Liabilities Ann.

1Y CHG

-18.6%

2Y CAGR

-54.9%

3Y CAGR

-52.5%

5Y CAGR

-19.2%

7Y CAGR

-5.8%

10Y CAGR

2.9%

Total Current Liabilities Annual Cr is falling faster than historical averages.

Total ShareHolders Funds Ann.

1Y CHG

8.2%

2Y CAGR

-10.3%

3Y CAGR

-27.7%

5Y CAGR

-18.4%

7Y CAGR

-9%

10Y CAGR

-2.3%

Total ShareHolders Funds Annual growth is higher than historical averages.

Emergent Biosolutions Inc ROE, ROCE, book value, and debt-to-equity ratio as of Dec 2025 – 11 year history

Nested row level

Base Level

Reporting Type

Originally Reported

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

POSITIVE
Book Value Per Share Emergent Biosolutions Inc Book Value Per Share is $11 which is growth of 19.5% YoY.
NEUTRAL
ROE Emergent Biosolutions Inc ROE is 0% which is growth of 0% YoY.

Emergent Biosolutions Inc, Ratios, standalone, All financials are in USD Million and price data in USD
Indicator	CAGR 3 Yrs	CAGR 5 Yrs	Dec '25	Dec '24	Dec '23	Dec '22	Dec '21	Dec '20	Dec '19	Dec '18	Dec '17	Dec '16	Dec '15
ROA_A RoA Ann. %	-	-	-	-11.86%	-30.48%	-7.31%	7.90%	11.71%	2.39%	3.80%	8.10%	5.14%	6.32%
ROE_A ROE Ann. %	-	-	-	-33.67%	-74.84%	-14.91%	15.06%	24.07%	5.19%	6.52%	10.95%	8.24%	10.36%
ROIC_Q ROIC %	-	-	-	-1.7	-1.9	-2.9	8.1	8.6	2.8	0.2	3.7	4.6	3.9
OPMPCT_A OPM Ann. %	-	-12%	15.92%	-8.04%	-19.70%	-15.38%	23.77%	30.12%	11.60%	12.73%	25.34%	30.55%	24.02%
NBTO_A Inventory Turnover Ratio Ann.	-	-	-	2.1	2.1	2	2.3	2	2	1.9	1.8	1.7	1.7
ASETTO_A Asset Turnover Ann. %	-	-	-	0.6	0.4	0.4	0.6	0.6	0.4	0.4	0.5	0.3	0.4
WCTO_A Working Capital Turnover Ann.	-	-6.3%	1.3	2.3	36.3	-56.2	1.9	1.8	2.1	1.7	1.3	0.9	0.9
QuickRatio_A Quick Ratio Ann.	-	-	-	1.6	0.5	0.7	2.3	2.2	2.1	1.9	3.2	4	4.4
CRATIO_A Current Ratio Ann.	-	-	-	3.7	1	1	3.4	3.1	3.2	3.1	4.9	4.8	5.4
IC_A Interest Coverage Ratio Ann.	-	-	-	-1	-7.3	-4.9	10.1	14	3	9.2	19	14	14.8
LTDE_A LT Debt To Equity Ann.	-	-	-	1.4	0.7	0.3	0.5	0.6	0.7	0.8	0	0.4	0.4

*All financials are in USD Million and price data in USD

Add metric to table

Search...

Emergent Biosolutions Inc cash flow: net, operating, investing, and financing flows as of Dec 2025 – 11 year history

Nested row level

Base Level

Reporting Type

Originally Reported

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

POSITIVE
Cash From Operating Activity Emergent Biosolutions Inc Dec-2025 Cash From Operating Activity is $171 Million which is growth of 190.6% YoY.
POSITIVE
Net Cash Flow Emergent Biosolutions Inc Dec-2025 Net Cash Flow is $103 Million which is growth of 1795.1% YoY.

Emergent Biosolutions Inc, Cash Flow, standalone, All financials are in USD Million and price data in USD
Indicator	CAGR 3 Yrs	CAGR 5 Yrs	Dec '25	Dec '24	Dec '23	Dec '22	Dec '21	Dec '20	Dec '19	Dec '18	Dec '17	Dec '16	Dec '15
CFO_A Cash from Operating Act. Ann. ⌄	-	-20.5%	170.6	58.7	-206.3	-34.1	321.1	536	188	41.8	208.1	53.5	44.5
ProfitLossFromContinuingOperations_A Profit From Continuing Operations Ann.	-	-29.6%	52.6	-190.6	-760.5	-223.8	230.9	305.1	54.5	62.7	82.6	51.8	62.9
DepreciationAmortizationDepletion_A Depreciation Amortization Depletion Ann.	-12.6%	-3.5%	95.8	108.8	125.1	143.3	123.8	114.5	110.7	62.2	42.6	38.2	35.3
DepreciationAndAmortization_A Depreciation And Amortization Ann.	-12.6%	-3.5%	95.8	108.8	125.1	143.3	123.8	114.5	110.7	62.2	42.6	38.2	35.3
DeferredTax_A Deferred Tax Ann.	-	-	-4	-5.5	-8.9	-19	46.9	-2.4	-1.1	8.6	3.3	5.2	3.5
DeferredIncomeTax_A Deferred Income Tax Ann.	-	-	-4	-5.5	-8.9	-19	46.9	-2.4	-1.1	8.6	3.3	5.2	3.5
EmployeesStockOptions_A ESOPs Ann.	-28.9%	-20.5%	16.2	18	23.1	45.1	42.4	51	26.7	23.2	15.2	18.5	15.9
OtherNonCashItems_A Other Non Cash Items Ann.	-8%	-19.4%	10.2	14.5	34.5	13.1	9	30	27.6	4.2	8.8	-10.4	-10.3
ChangeInWorkingCapital_A Change In Working Capital Ann.	-	-	-22.4	88.7	-70.3	0.5	-156.4	8.8	-42.4	-119.1	53.7	-45.5	-65.9
ChangeInReceivables_A Change In Receivables Ann.	-39.4%	-12.2%	25.5	-24.4	-21.6	114.7	-48.2	49	-19.9	-94.2	-4.8	-27	-67.9
ChangeInInventory_A Change In Inventory Ann.	-	-	-30.3	-24.5	0.6	-51.9	-44	-83.2	-16.7	-1.9	6.1	-9	-11.3
ChangePayablesAccruedExpense_A Change Payables Accrued Expense Ann.	-	-	-35.9	-38.9	-55.5	-80.6	-7.7	61	5.6	-10.2	21.1	-11.9	7.5
ChangeInOtherCurrentAssets_A Change In Other Current Assets Ann.	-	-	-	-	-	-	-	-	-	-	-	-	-
ChangeInOtherCurrentLiabilities_A Change In Other Current Liabilities Ann.	-	-	-	-	-	-	-	-	-	-	-	-	-
ChangeInOtherWorkingCapital_A Change In Other Working Capital Ann.	-44.3%	-10%	6.6	6.6	-5.5	38.2	-31.8	11.2	16	-4.9	35.1	4.6	3.5
CFI_A Cash from Investing Act. Ann. ⌄	-	-	69.4	125.2	212.3	-381.3	-225	-151	-96.9	-897.2	-249.9	-76.3	-45.5
NetPPEPurchaseAndSale_A Net PPE Purchase & Sale Ann.	-	-	24.4	-15	-51.6	-115.8	-225	-141	-86.9	-72.1	-54.8	-76.3	-44.8
PurchaseOfPPE_A Purchase Of PPE Ann.	-	-	-13.8	-22.9	-51.6	-115.8	-225	-141	-86.9	-72.1	-54.8	-76.3	-44.8
NetBusinessPurchaseAndSale_A Net Business Purchase & Sale Ann.	-	-		110.2	270.2	-	-			-827.7	-		-0.7
PurchaseOfBusiness_A Purchase Of Business Ann.	-	-	-	-	-	-	-			-827.7	-		-0.7
PurchaseOfInvestment_A Purchase Of Investment Ann.	-	-	-	-	-	-	-	-	-	-	-	-	-
SaleOfInvestment_A Sale Of Investment Ann.	-	-	-	-	-	-	-	-	-	-	-	-	-
NetOtherInvestingChanges_A Net Other Investing Changes Ann.	-	-	45	30	-6.3	-243.7	-	-10	-10	2.6	-195.1	-	-
CFA_A Cash from Financing Act. Ann. ⌄	-	-	-136.6	-190	-535.7	481.2	-140.8	69.7	-35.7	788.7	-51.4	-18.6	33.5
NetIssuancePaymentsOfDebt_A Net Issuance Payments Of Debt Ann.	-	-	-108.7	-198.4	-543.4	564.2	-35.9	62.9	13.7	795.2	-20		2
NetLongTermDebtIssuance_A Net Long Term Debt Issuance Ann.	-	-	-108.7	-198.4	-543.4	-33.8	-35.9	435.9	-11.3	795.2			2
NetShortTermDebtIssuance_A Net ST Debt Issuance Ann.	-	-	-	-	-	598		-373	25	-	-20	-	-
NetCommonStockIssuance_A Net Common Stock Issuance Ann.	-	-	-24.9	9.3	8.4	-82.1	-106			-0.1	-33.1		-0.1
CommonStockIssuance_A Common Stock Issuance Ann.	-	-		9.3	8.4	-	-	-	-	-	-	-	-
CommonStockPayments_A Common Stock Payments Ann.	-	-	-24.9			-82.1	-106			-0.1	-33.1		-0.1
dividend_1Y_actual Dividend 1year	-	-
DividendPerShare_A Dividend Per Share Ann.	-	-	-	-	-	-	-	-	-	-	-	-	-
NetOtherFinancingCharges_A Net Other Financing Charges Ann.	-	-	-5.2	-15.8	-2.5	-5.9	-15	-25	-57.8	-22.3	-17.7	-35.8	5.6
CashAndCashEquivalentEndOfYear_A Cash Plus Cash Eqv. End Of Year Ann.	-31.2%	-19.6%	209.1	105.6	111.7	642.6	576.3	621.5	168	112.4	178.3	271.5	312.8
NetIncDecInCashAndCashEquivalents_A Net Increase In Cash Plus Cash Eqv.s Ann.	16.3%	-25.6%	103.4	-6.1	-529.7	65.8	-44.9	454.5	55.2	-66.7	-93.2	-41.4	32.5
CashAndCashEquivalentBeginOfYear_A Cash Plus Cash Eqv. Begin Of Year Ann.	-43.2%	-8.9%	105.6	111.7	642.6	576.3	621.5	168	112.4	179.3	271.5	312.8	280.5
IncomeTaxPaidSupplementalData_A Income Tax Paid Supplemental Data Ann.	86.2%	-18.2%	40	26.5	52.8	6.2	71.6	109.3	30.8	14	12	10.1	28.3
InterestPaidSupplementalData_A Interest Paid Supplemental Data Ann.	14.6%	18.8%	49.7	64	68.3	33	30.4	21	34.5	10.2	8.4	8.2	7.8
CapitalExpenditure_A Capex Ann.	-	-	-13.8	-22.9	-51.6	-137.6	-225	-141	-86.9	-72.1	-54.8	-76.3	-44.8
IssuanceOfCapitalStock_A Issuance Of Capital Stock Ann.	-	-		9.3	8.4	-	-	-	-	-	-	-	-
IssuanceOfDebt_A Issuance Of Debt Ann.	-	16.9%		284	20	598		450	130	798			2
RepaymentOfDebt_A Repayment Of Debt Ann.	-	-	-108.7	-482.4	-563.4	-33.8	-35.9	-387.1	-116.3	-2.8	-20		-
RepurchaseOfCapitalStock_A Repurchase Of Capital Stock Ann.	-	-	-24.9			-82.1	-106			-0.1	-33.1		-0.1
FreeCashFlow_A Free Cash Flow Ann.	-	-16.9%	156.8	35.8	-257.9	-171.7	96.1	395	101.1	-30.3	153.3	-22.8	-0.4

*All financials are in USD Million and price data in USD

Add metric to table

Search...

Cash from Operating Act. Ann.

1Y CHG

190.6%

5Y CAGR

-20.5%

7Y CAGR

22.3%

10Y CAGR

14.4%

Cash from Operating Activity Annual growth is stable compared to historical averages.

Cash from Investing Act. Ann.

1Y CHG

-44.6%

2Y CAGR

-42.8%

Cash from Investing Activity Annual is falling faster than historical averages.

Forecaster
Quarterly
Competitors/Peers
Annual
Balance Sheet
Ratios
Cash Flow

50.85% Fall from 52W High

Emergent Biosolutions Inc quarterly and annual earnings report: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents

Emergent Biosolutions Inc - Forecaster

Forecaster Analyst Estimates for Emergent Biosolutions Inc share price target, revenues, EPS, net income and more

Emergent Biosolutions Inc - Earnings Report - Quarterly Results

Emergent Biosolutions Inc quarterly results: revenue, profit, and P&L – 13 quarter history

Quarterly Revenue Emergent Biosolutions Inc Jun-2026 Quarterly Revenue is $227 Million which is growth of 74.1% YoY.

Quarterly Net Profit Emergent Biosolutions Inc Jun-2026 Quarterly Net Profit is $-180 Million which is growth of -1401.7% YoY.

Emergent Biosolutions Inc - Competitors/Peers

Emergent Biosolutions Inc competitor comparison and performance snapshot within industry

Emergent Biosolutions Inc - Earnings Report - Annual Results

Emergent Biosolutions Inc annual results: revenue, profit, P&L, and margins as of Dec 2025 – 11 year history

Annual Revenue Emergent Biosolutions Inc Dec-2025 Annual Revenue is $705 Million which is growth of -30.4% YoY.

Annual Net Profit Emergent Biosolutions Inc Dec-2025 Annual Net Profit is $53 Million which is growth of 127.6% YoY.

Emergent Biosolutions Inc - Balance Sheet

Emergent Biosolutions Inc balance sheet as of Dec 2025: assets, liabilities, reserves, and borrowings – 11 year history

Total Shareholders Fund Emergent Biosolutions Inc Dec-2025 Total Shareholders Fund is $523 Million which is growth of 8.2% YoY.

Total Assets Emergent Biosolutions Inc Dec-2025 Total Assets is $1,319 Million which is growth of -5.1% YoY.

Emergent Biosolutions Inc - Ratios

Emergent Biosolutions Inc ROE, ROCE, book value, and debt-to-equity ratio as of Dec 2025 – 11 year history

Book Value Per Share Emergent Biosolutions Inc Book Value Per Share is $11 which is growth of 19.5% YoY.

ROE Emergent Biosolutions Inc ROE is 0% which is growth of 0% YoY.

Emergent Biosolutions Inc - Cash Flow

Emergent Biosolutions Inc cash flow: net, operating, investing, and financing flows as of Dec 2025 – 11 year history

Cash From Operating Activity Emergent Biosolutions Inc Dec-2025 Cash From Operating Activity is $171 Million which is growth of 190.6% YoY.

Net Cash Flow Emergent Biosolutions Inc Dec-2025 Net Cash Flow is $103 Million which is growth of 1795.1% YoY.